The Study Of Fluconazole For Vulvovaginal Candidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

March 5, 2013

Primary Completion Date

November 22, 2013

Study Completion Date

November 22, 2013

Conditions
Vulvovaginal Candidiasis
Interventions
DRUG

Fluconazole

Single oral dose of 150mg Fluconazole

Trial Locations (10)

070-8003

Ai WOMEN'S CLINIC, Asahikawa

108-0071

Shirokane Ladies' Clinic, Minato-ku

140-0013

Takane Medical Clinic, Shinagawa-ku

167-0051

Suzuran Clinic, Suginami-ku

810-0011

Mori Ladies Clinic, Fukuoka

502-0914

IZUMI Ladies' Clinic, Gifu

892-0845

Tetsu-Nakamura Obstetrics and Gynecology Department Internal Medicine, Kagoshima

700-0901

Women's Clinic Kamimura, Okayama

542-0081

Sutou Ladies Clinic, Osaka

542-0086

Hayakawa Clinic, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01806623 - The Study Of Fluconazole For Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter